Cargando…

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

BACKGROUND: Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival, which is highly variable amongst patients with comparable conventional prognosticators. Therefore molecular biomarkers are urgently needed to improve the prediction of survival in these patients. SRY (...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600089/ https://www.ncbi.nlm.nih.gov/pubmed/28692180 http://dx.doi.org/10.1002/bjs.10553

Ejemplares similares

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
por: van der Wilk, B. J., et al.
Publicado: (2020)

Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?
por: Gotink, Annieke W, et al.
Publicado: (2018)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017)

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission
por: Grotenhuis, B.A., et al.
Publicado: (2009)

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
por: Suzuki, Lucia, et al.
Publicado: (2019)

Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines
por: Eini, Ronak, et al.
Publicado: (2014)

Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis
por: Janmaat, Vincent T., et al.
Publicado: (2017)

Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case–control study
por: van Olphen, Sophie H., et al.
Publicado: (2016)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2
por: van der Zijden, Charlène J., et al.
Publicado: (2023)

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
por: Valkema, Maria J, et al.
Publicado: (2023)

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
por: Boonstra, Jurjen J, et al.
Publicado: (2011)

Alterations in the Ca(2+) toolkit in oesophageal adenocarcinoma
por: Cutliffe, Alana L., et al.
Publicado: (2021)

International benchmarking in oesophageal and gastric cancer surgery
por: Busweiler, L. A. D., et al.
Publicado: (2018)

Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue
por: Thimsen, Vivian, et al.
Publicado: (2017)

Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix
por: Moshi, Jobran M., et al.
Publicado: (2020)

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
por: van Nistelrooij, Anna M. J., et al.
Publicado: (2017)

Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison
por: Eyck, Ben M, et al.
Publicado: (2022)

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma
por: van Nistelrooij, A. M. J., et al.
Publicado: (2017)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
por: Valkema, Maria J., et al.
Publicado: (2023)

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study
por: Hermus, Merel, et al.
Publicado: (2022)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
por: de Boer, A G E M, et al.
Publicado: (2002)

SOX17 expression and its down‐regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma
por: Hopman, Anton N H, et al.
Publicado: (2019)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116
por: Wijnhoven, B P L, et al.
Publicado: (2000)

Tonsillar metastasis of oesophageal adenocarcinoma
por: Struijs, Bram, et al.
Publicado: (2007)

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer
por: Grotenhuis, B. A., et al.
Publicado: (2010)

Progressive silencing of p14ARF in oesophageal adenocarcinoma
por: Huang, Yinghui, et al.
Publicado: (2009)

Painful ovulation in a 46,XX SRY −ve adult male with SOX9 duplication
por: Shankara Narayana, Nandini, et al.
Publicado: (2017)

Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies
por: Zhou, Jing-dong, et al.
Publicado: (2018)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
por: Noordman, Bo Jan, et al.
Publicado: (2018)

Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial
por: van Vulpen, J K, et al.
Publicado: (2021)

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression
por: Koppert, L B, et al.
Publicado: (2004)

Allele-specific repression of Sox2 through the long non-coding RNA Sox2ot
por: Messemaker, Tobias C., et al.
Publicado: (2018)

Early diagnosis of oesophageal cancer
por: Bird-Lieberman, E L, et al.
Publicado: (2009)

Oesophageal cancer: exploring controversies overview of experts’ opinions of Austria, Germany, France, Netherlands and Switzerland
por: Putora, Paul Martin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nk498ukasrsr92cpk1nob61h9s